Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vaccine Effectiveness × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2548 Uterine Cervical Neoplasms 1668 Endometrial Neoplasms 1000 Fallopian Tube Neoplasms 725 Carcinoma, Ovarian Epithelial 675 Breast Neoplasms 669 Neoplasms 433 Carcinoma, Non-Small-Cell Lung 372 Colorectal Neoplasms 367 Stomach Neoplasms 300 Pancreatic Neoplasms 300 Uterine Cervical Dysplasia 270 Prostatic Neoplasms 260 Lung Neoplasms 249 Melanoma 246 Neoplasm Metastasis 213 Peritoneal Neoplasms 196 Carcinoma, Renal Cell 190 Sarcoma 189 Urinary Bladder Neoplasms 188 Head and Neck Neoplasms 188 Esophageal Neoplasms 187 Recurrence 183 Triple Negative Breast Neoplasms 180 Uterine Neoplasms 175 Vulvar Neoplasms 173 Squamous Cell Carcinoma of Head and Neck 166 Colonic Neoplasms 160 Papillomavirus Infections 150 Small Cell Lung Carcinoma 125

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡